Pharma Journalist -

Clinical stage Biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary diseases, Pulmatrix sought approval of its Clinical Trial Application from…
Read More...

Amgen affirms optimistic outcomes for Phase 3b LIBERTY study evaluating the efficacy and safety of Aimovig (erenumab) 140 mg in patients with episodic migraine who had experienced two…
Read More...

SMi’s global panel of speakers will strengthen your knowledge in key topics such as high potent ingredients, ADC payloads, PK-PD technological advancements, warheads and site…
Read More...

Medrobotics Corporation asserted that FDA has granted clearance to promulgate the Flex Robotics System for robot-assisted visualization in general surgical, gynecological and thoracic…
Read More...

AstraZeneca and Merck asserted the sanctioning of LYNPARZA tablets for patients with platinum-sensitive relapsed ovarian cancer, regardless of their BRCA mutation status, who responded…
Read More...

Bristol-Myers Squibb Company asserted new data from a cohort of the Phase 2 CheckMate-142 trial assessing Opdivo and Yervoy for the treatment of patients with DNA mismatch repair…
Read More...

SymBio Pharmaceuticals commences a Phase 1 study in Japan for oral TREAKISYM in progressive solid tumors afflicted patients. SymBio sought approval for TREAKISYM injectables…
Read More...

In a bid to offer qualitative bioanalytical and DMPK study services, Concept Life Sciences and Alderly Analytical venture into partnership agreement enumerating having access to…
Read More...

Selexis SA appoints Alberto Garotti as its Chief Financial Officer. Selexis is a life sciences company focusing on revolutionizing mammalian cell line generation technology. Mr. Garotti…
Read More...

Biohaven Pharmaceuticals declared proceeding with its clinical investigation of BHV-5000 as intimated by the US Food and Drug Administration. Enrollment of subjects has begun for the…
Read More...